AVBP
ArriVent BioPharma, Inc.
13.51
+0.02 (+0.11%)
52w low 11.36
35.83 high
8.8% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | -- | 112.77M | 112.67M | 45.54M | 62.10M | 154.68M | |
| Receivables | 505.00K | 505.00K | 505.00K | 60.00K | -- | -- | |
| Current Assets | -- | 250.15M | 321.22M | 332.90M | 348.70M | 394.17M | |
| Net PP&E | -- | 85.00K | 49.00K | 13.00K | 370.00K | 370.00K | |
| Total Assets | -- | 269.51M | 326.56M | 333.17M | 349.30M | 394.72M | |
| Current Liabilities | -- | 19.64M | 21.56M | 25.95M | 25.00M | 27.84M | |
| Total Debt | -- | 98.00K | 56.00K | 14.00K | 419.00K | 351.00K | |
| Total Liabilities | -- | 19.64M | 21.56M | 25.95M | 25.32M | 27.88M | |
| Retained Earnings | -- | -334.12M | -369.10M | -404.64M | -447.96M | -497.85M | |
| Shareholders Equity | -- | 249.87M | 305.00M | 307.22M | 323.98M | 366.84M | |
| Working Capital | -- | 230.51M | 299.66M | 306.95M | 323.70M | 366.33M | |
| Shares Outstanding | -- | 37.49M | 40.85M | 42.45M | 45.31M | 48.32M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--